Campbell & CO Investment Adviser LLC

Position in ARGX — Argenx SE

CIK 1353570 BALTIMORE, MD

Position in ARGX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,597,078

-$2,802,220 QoQ

Shares Held

9,034

-19.2% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.38%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Campbell & CO Investment Adviser LLC holds $45,287,811 across 43 Biotechnology names. ARGX ranks #1 (14.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE This page	9,034	$6,597,078
2	KRYS	Krystal Biotech, Inc.	17,795	$4,596,804
3	CRNX	Crinetics Pharmaceuticals, Inc.	83,617	$3,036,969
4	RVMD	Revolution Medicines, Inc.	29,130	$2,832,892
5	VRTX	Vertex Pharmaceuticals Inc / Ma	5,580	$2,491,693
6	TECH	BIO-TECHNE Corp	41,339	$2,160,376
7	RPRX	Royalty Pharma plc	31,202	$1,496,759
8	PRTA	Prothena Corp Public Ltd Co	142,587	$1,385,945

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,597,078	9,034	-19.2%	Shares	Sole	2026-05-15
2025-12-31	$9,399,298	11,177	+272.7%	Shares	Sole	2026-02-12
2025-09-30	$2,211,942	2,999	-45.8%	Shares	Sole	2025-10-28
2025-06-30	$3,051,002	5,535	+137.8%	Shares	Sole	2025-08-07
2025-03-31	$1,377,861	2,328	+171.3%	Shares	Sole	2025-05-14
2023-06-30	$334,388	858	-78.6%	Shares	Sole	2023-08-11
2023-03-31	$1,490,692	4,001	+11.3%	Shares	Sole	2023-05-11
2022-12-31	$1,361,893	3,595	-18.8%	Shares	Sole	2023-02-14
2022-09-30	$1,563,658	4,429	+210.2%	Shares	Sole	2022-11-14
2022-06-30	$541,040	1,428	-38.9%	Shares	Sole	2022-08-09
2022-03-31	$736,879	2,337	+29.8%	Shares	Sole	2022-05-09
2021-12-31	$630,342	1,800	+38.5%	Shares	Sole	2022-02-10
2021-09-30	$392,600	1,300	—	Shares	Sole	2021-11-10
No filing history on record for this holder in this stock.